Sumbangan 15 September 2024 – 1 Oktober 2024
Tentang pengumpulan dana
pencarian buku
buku
Sumbangan:
68.5% dicapai
Masuk
Masuk
pengguna terdaftar memiliki akses ke:
rekomendasi pribadi
Bot Telegram
riwayat unduhan
mengirim ke alamat email atau Kindle
manajemen daftar buku
penyimpanan ke Favorit
Pribadi
Permintaan untuk buku
Pengkajian
Z-Recommend
Daftar buku
Yang paling populer
Kategori
Partisipasi
Mendukung
Unggahan
Litera Library
Menyumbangkan buku kertas
Menambah buku kertas
Search paper books
LITERA Point saya
Pencarian kata kunci
Main
Pencarian kata kunci
search
1
Advocate Study Pocket Protocol (CL010_168)
MedPace
ChemoCentryx
ccx
thc
dose
ancl
placebo
cyc
ents
bvas
protocol
oral
protoco
stucly
patients
patient
avacopan
weck
weeks
prior
azathi
events
adverse
anti
predni
rate
laboratory
acco
reco
november
ritu
remi
renal
chemocentryx
ial
sone
cati
dosc
lnc
clini
cl0
cnt
gator
glucoco
event
items
medi
stud
urin
ient
unt
wbc
Tahun:
2016
Bahasa:
english
File:
PDF, 4.71 MB
Tag Anda:
0
/
0
english, 2016
2
KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
Kidney Disease: Improving Global Outcomes (KDIGO)
Kidney Disease: Improving Global Outcomes (KDIGO) ANCA Vasculitis Work Group & Jürgen Floege & David R.W. Jayne & Jan-Stephan F. Sanders & Vladimír Tesar & Brad H. Rovin
anca
vasculitis
kidney
patients
rituximab
cyclophosphamide
evidence
therapy
maintenance
remission
guideline
clinical
azathioprine
induction
relapse
antibody
cytoplasmic
versus
antineutrophil
certainty
figure
outcomes
glucocorticoids
kdigo
risk
s116
s71
suppl
studies
international.org
www.kidney
plasma
recommendation
pr3
rate
recommendations
dose
glucocorticoid
nephrology
supplementary
effect
rcts
immunosuppressive
oral
compared
glomerular
gfr
systematic
avacopan
mpo
Tahun:
2024
Bahasa:
english
File:
PDF, 1.87 MB
Tag Anda:
0
/
0
english, 2024
3
KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
Kidney Disease: Improving Global Outcomes (KDIGO)
Kidney Disease: Improving Global Outcomes (KDIGO) ANCA Vasculitis Work Group & Jürgen Floege & David R.W. Jayne & Jan-Stephan F. Sanders & Vladimír Tesar & Brad H. Rovin
anca
vasculitis
kidney
patients
rituximab
cyclophosphamide
evidence
therapy
maintenance
remission
guideline
clinical
azathioprine
induction
relapse
antibody
cytoplasmic
versus
antineutrophil
certainty
figure
outcomes
glucocorticoids
kdigo
risk
s116
s71
suppl
studies
international.org
www.kidney
plasma
recommendation
pr3
rate
recommendations
dose
glucocorticoid
nephrology
supplementary
effect
rcts
immunosuppressive
oral
compared
glomerular
gfr
systematic
avacopan
mpo
Tahun:
2024
Bahasa:
english
File:
PDF, 1.56 MB
Tag Anda:
0
/
0
english, 2024
1
Pindah ke
tautan ini
atau temukan bot "@BotFather" di Telegram
2
Kirimlah perintah /newbot
3
Masukkan nama untuk bot Anda
4
Masukkan nama pengguna untuk bot
5
Salin pesan terbaru dari BotFather dan masukkannya di sini
×
×